Sherwin-Williams (NYSE:SHW) Given New $425.00 Price Target at BMO Capital Markets

Sherwin-Williams (NYSE:SHW) had its target price hoisted by stock analysts at BMO Capital Markets from $400.00 to $425.00 in a note issued to investors on Monday, Benzinga reports. The firm currently has an “outperform” rating on the specialty chemicals company’s stock. BMO Capital Markets’ target price suggests a potential upside of 12.21% from the stock’s current price.

Other research analysts have also issued research reports about the company. Morgan Stanley boosted their price target on Sherwin-Williams from $338.00 to $375.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 24th. Wells Fargo & Company boosted their target price on shares of Sherwin-Williams from $320.00 to $350.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 24th. Jefferies Financial Group upped their target price on shares of Sherwin-Williams from $392.00 to $415.00 and gave the company a “buy” rating in a report on Monday, August 26th. Redburn Atlantic upgraded shares of Sherwin-Williams to a “strong-buy” rating in a research note on Thursday, July 18th. Finally, Evercore ISI increased their price target on Sherwin-Williams from $365.00 to $380.00 and gave the company an “outperform” rating in a research note on Friday, August 30th. One research analyst has rated the stock with a sell rating, six have given a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Sherwin-Williams currently has an average rating of “Moderate Buy” and an average price target of $370.39.

Sherwin-Williams Price Performance

Shares of SHW stock traded down $3.99 during trading hours on Monday, hitting $378.74. 416,007 shares of the company’s stock were exchanged, compared to its average volume of 1,566,046. The stock’s 50-day moving average is $359.69 and its 200-day moving average is $329.68. The company has a debt-to-equity ratio of 2.17, a current ratio of 0.81 and a quick ratio of 0.50. Sherwin-Williams has a 52 week low of $232.06 and a 52 week high of $385.25. The stock has a market cap of $95.54 billion, a price-to-earnings ratio of 40.34, a price-to-earnings-growth ratio of 3.00 and a beta of 1.17.

Sherwin-Williams (NYSE:SHW) last announced its quarterly earnings results on Tuesday, July 23rd. The specialty chemicals company reported $3.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.51 by $0.19. Sherwin-Williams had a net margin of 10.92% and a return on equity of 75.58%. The company had revenue of $6.27 billion during the quarter, compared to analyst estimates of $6.33 billion. During the same quarter in the previous year, the business earned $3.29 EPS. The firm’s revenue was up .5% on a year-over-year basis. As a group, research analysts forecast that Sherwin-Williams will post 11.47 EPS for the current year.

Insider Buying and Selling

In other Sherwin-Williams news, CFO Allen J. Mistysyn sold 14,520 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $366.83, for a total transaction of $5,326,371.60. Following the completion of the transaction, the chief financial officer now owns 63,520 shares in the company, valued at approximately $23,301,041.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Sherwin-Williams

Institutional investors have recently added to or reduced their stakes in the business. Waterloo Capital L.P. acquired a new position in Sherwin-Williams during the 4th quarter worth approximately $360,000. Valeo Financial Advisors LLC increased its stake in Sherwin-Williams by 7.9% during the 2nd quarter. Valeo Financial Advisors LLC now owns 2,636 shares of the specialty chemicals company’s stock valued at $787,000 after purchasing an additional 193 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its holdings in Sherwin-Williams by 7.2% during the first quarter. Massmutual Trust Co. FSB ADV now owns 1,533 shares of the specialty chemicals company’s stock worth $532,000 after buying an additional 103 shares during the last quarter. Brevan Howard Capital Management LP lifted its stake in shares of Sherwin-Williams by 259.1% in the fourth quarter. Brevan Howard Capital Management LP now owns 6,998 shares of the specialty chemicals company’s stock valued at $2,183,000 after buying an additional 5,049 shares in the last quarter. Finally, Transcend Capital Advisors LLC raised its holdings in shares of Sherwin-Williams by 24.1% in the 2nd quarter. Transcend Capital Advisors LLC now owns 7,805 shares of the specialty chemicals company’s stock worth $2,329,000 after acquiring an additional 1,514 shares during the last quarter. 77.67% of the stock is owned by institutional investors and hedge funds.

About Sherwin-Williams

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.